19.12.2014
SARTORIUS AG DE0007165607
DGAP-Adhoc: SARTORIUS AG: Sartorius to Sell Its Industrial Technologies Division to Minebea Co., Ltd.
SARTORIUS AG / Key word(s): Disposal
19.12.2014 19:16
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Goettingen, December 19, 2014 - Sartorius, a leading international
laboratory and pharmaceutical equipment provider, is selling its Industrial
Technologies Division (Intec) to the Japanese Minebea Co., Ltd. (Minebea)
and their partner, the Development Bank of Japan Inc. The respective
contract was signed today. The sales price will be determined as a multiple
of the Intec division's 2014 operating profit and be fixed in early 2015.
The contractual parties agreed on a 7.5 multiple on the division's 2014
operating EBITDA. The transaction is subject to customary closing
conditions, including regulatory clearance by the antitrust authorities,
and is expected to close in the first quarter of 2015.
In fiscal 2013, the Intec Division earned sales revenue of 102 million
euros and achieved an underlying EBITDA margin of 10.1%.
Conference call and webcast
Dr. Joachim Kreuzburg, CEO and Executive Board Chairman of Sartorius, will
discuss the transaction with analysts and investors on Monday, December 22,
2014, at 3:30 p.m. Central European Time (CET) in a teleconference. You may
dial into the teleconference starting at 3:20 p.m. CET at the following
numbers:
Germany: +49(0)69 2222 10640
France: +33(0)1 76 77 22 40
UK: +44(0)20 3427 1923
USA: +1646 254 3387
The dial-in code is as follows: 7586730; to view the webcast, log onto:
http://www.sartorius.de/de/konzern/investor-relations/sartorius-ag/
This press release contains statements about the future development of the
Sartorius Group. The content of these statements cannot be guaranteed as
they are based on assumptions and estimates that harbor certain risks and
uncertainties. This is a translation of the original German-language press
release. Sartorius shall not assume any liability for the correctness of
this translation. The original German press release is the legally binding
version. Furthermore, Sartorius reserves the right not to be responsible
for the topicality, correctness, completeness or quality of the information
provided. Liability claims regarding damage caused by the use of any
information provided, including any kind of information which is incomplete
or incorrect, will therefore be rejected.
Contact
Petra Kirchhoff | Vice President of Corporate Communications
+49 (0)551.308.1686 | [email protected]
19.12.2014 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: SARTORIUS AG
Weender Landstraße 94 - 108
37075 Göttingen
Germany
Phone: +49.(0)551-308.0
Fax: +49.(0)551-308.3289
E-mail: [email protected]
Internet: www.sartorius.com
ISIN: DE0007165607, DE0007165631
WKN: 716560 , 716563
Listed: Regulierter Markt in Frankfurt (Prime Standard), Hannover;
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
SARTORIUS AG ISIN: DE0007165607 können Sie bei EQS abrufen
Medtech , 716560 , SRT , XETR:SRT